<!DOCTYPE html><html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no"><link rel="stylesheet" href="css/main.min.css"><script src="js/all.min.js"></script><script type="text/javascript">var slideNumber = 3</script></head><body class="s3"><div class="content-wrap"><nav><div onclick="iRep.go(1)" class="home-button"></div><ul><li onclick="iRep.go(3)" class="real-world-evidence active"><span>REAL WORLD</span></li><li onclick="iRep.go(4)" class="evidence"><span>EVIDENCE</span></li><li onclick="iRep.go(12)" class="reversal"><span>REVERSAL</span></li><li onclick="iRep.go(14)" class="take-action"><span>COST</span></li><li onclick="iRep.goToolbox()" class="toolbox"><span>TOOLBOX</span></li><li onclick="iRep.go(16)" class="pi"><span>PI</span></li></ul></nav><div class="page-nav"><div onclick="iRep.nextSlide()" class="page-next"></div></div><article><div class="box-big"><h3>Pradaxa<sup>&reg;</sup>: Real<span class="sep">-</span>world evidence vs warfarin in more than<span> <b>300,000</b> PATIENTS</span><sup>1<span class="sep2">-</span>7</sup></h3><div class="boxes"><div class="box"><div class="text">FDA <br/>Medicare study</div><div class="text2">134,000<span> PATIENTS<sup>1</sup></span></div></div><div class="box"><div class="text">US Dept of <br/> Defense database</div><div class="text2">25,000<span> PATIENTS<sup>2</sup></span></div></div><div class="box"><div class="text">2 US insurance <br/> databases</div><div class="text2">38,000<span> PATIENTS<sup>3</sup></span></div></div><div class="box"><div class="text">Danish <br/> observational <br/> studies</div><div class="text2">21,000<span> PATIENTS<sup>4,5</sup></span></div></div><div class="box"><div class="text">US insurance <br/> database</div><div class="text2">64,000<span> PATIENTS<sup>6</sup></span></div></div><div class="box"><div class="text">3 Danish health <br/> registries</div><div class="text2">61,000<span> PATIENTS<sup>7</sup></span></div></div></div><div class="under-text">The safety and efficacy of Pradaxa<sup>®</sup> has been confirmed by the largest body of real-world evidence vs warfarin for any NOAC<sup>1–10</sup></div></div></article><div class="overlay"></div><div class="sidebar"><ul><li class="graph-tab tab"></li><li class="info-tab tab"></li><li class="references-tab tab"></li></ul><div class="panel"><div class="close-button"></div><div class="content references"><div class="text"><b>References: 1.</b> Graham DJ,<em> et al. Circulation</em> 2015;131:157–64.<b> 2.</b> Villines TC,<em> et al. Thromb Haemost</em> 2015;114(6):1290–8.<b> 3.</b> Seeger JD,<em> et al. Thromb Haemost <br/></em> 2015;114(6):1277–89.<b> 4.</b> Larsen TB,<em> et al. Am J Med</em> 2014;127:650–656.<b> 5.</b> Larsen TB,<em> et al. Am J Med</em> 2014;127:329–336.<b> 6.</b> Lauffenburger JC,<em> et al. J Am Heart <br/> Assoc</em> 2015;4:eO01798.<b> 7.</b> Larsen TB,<em> et al. BMJ.</em> 2016;353:i3189.<b> 8.</b> Connolly SJ,<em> et al. N Engl J Med</em> 2009;361:1139–1151.<b> 9.</b> Connolly SJ,<em> et al. N Engl J Med <br/></em> 2010;363:1875–1876.<b> 10.</b> Connolly SJ,<em> et al. N Engl J Med</em> 2014;371:1464–1465.<b> 11.</b>Boehringer Ingelheim. Pradaxa<sup>®</sup> Summary of Product Characteristics.</div></div><div class="content graph"><h3 class="title">Real-world evidence outcomes are consistent with the RE-LY trial<sup>1,7-11</sup></h3><img src="img/s03/popup-chart.png"><div class="bottom-text"><div class="first-line">Graphs depict the hazard ratios and the associated 95% confidence intervals<br/></div><span>*&nbsp; Of the 134,414 patients, 67,207 were taking Pradaxa<sup>®</sup> (16% taking 75mg b.d., and 84% taking 150mg b.d.)<sup>1</sup><br/></span><span>&nbsp;&nbsp; 75mg b.d. is not licensed in Europe for this indication.<sup>11</sup><br/></span><span>† There was an increased incidence of major GI bleeding in the Pradaxa<sup>®</sup> group: 0.77% ARI, 28% RRI (p<0.001).<sup>1</sup></span></div></div><div class="content info"><h3 class="title">Major bleeding and mortality significantly reduced with <br/>Pradaxa<sup>®</sup> and apixaban vs warfarin<sup>7</sup></h3><img src="img/s03/popup-info.png"><img src="img/s03/popup-info-ref.png"></div></div></div></div></body></html>